对《乳腺癌中免疫检查点VISTA的表达》的更正
Correction to: Expression of the immune checkpoint VISTA in breast cancer.
作者信息
Zong Liju, Mo Shengwei, Yu Shuangni, Zhou Yuncan, Zhang Ming, Chen Jie, Xiang Yang
机构信息
Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No.1 Shuaifuyuan, Dongcheng District, Beijing, 100730, China.
Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No.1 Shuaifuyuan, Dongcheng District, Beijing, 100730, China.
出版信息
Cancer Immunol Immunother. 2020 Aug;69(8):1447. doi: 10.1007/s00262-020-02602-y.
Abstract
The original version of this article unfortunately contained a mistake. The correct information is given below.
摘要
很遗憾，本文的原始版本存在一处错误。正确信息如下。
相似文献
1
Correction to: Expression of the immune checkpoint VISTA in breast cancer.对《乳腺癌中免疫检查点VISTA的表达》的更正
Cancer Immunol Immunother. 2020 Aug;69(8):1447. doi: 10.1007/s00262-020-02602-y.
2
Correction to: Predictive value of positron emission tomography for the prognosis of immune checkpoint inhibitors (ICIs) in malignant tumors.更正：正电子发射断层扫描对恶性肿瘤中免疫检查点抑制剂（ICIs）预后的预测价值。
Cancer Immunol Immunother. 2020 Jun;69(6):937. doi: 10.1007/s00262-020-02541-8.
3
Correction to: Strategies for Predicting Response to Checkpoint Inhibitors.对《预测免疫检查点抑制剂反应的策略》的更正
Curr Hematol Malig Rep. 2019 Feb;14(1):62. doi: 10.1007/s11899-018-0488-0.
4
Correction to: Iatrogenic atrial septal defect: reassurance or inquisitiveness.对《医源性房间隔缺损：安心还是好奇》的勘误
J Interv Card Electrophysiol. 2019 Mar;54(2):201. doi: 10.1007/s10840-018-0442-z.
5
Correction to: Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura.对《血栓性血小板减少性紫癜患者重症监护病房管理专家声明》的勘误
Intensive Care Med. 2020 Mar;46(3):570-571. doi: 10.1007/s00134-019-05904-7.
6
Correction to: Influences to ADHD Problem Recognition: Mixed-Method Investigation and Recommendations to Reduce Disparities for Latino Youth.对《多动症问题认知的影响：混合方法调查及减少拉丁裔青少年差异的建议》的更正
Adm Policy Ment Health. 2018 Nov;45(6):978. doi: 10.1007/s10488-018-0888-4.
7
Correction to: Human ovarian cancer intrinsic mechanisms regulate lymphocyte activation in response to immune checkpoint blockade.对《人类卵巢癌内在机制调节免疫检查点阻断反应中的淋巴细胞激活》的修正
Cancer Immunol Immunother. 2020 Aug;69(8):1403-1408. doi: 10.1007/s00262-020-02601-z.
8
The Expression Pattern and Clinical Significance of the Immune Checkpoint Regulator VISTA in Human Breast Cancer.免疫检查点调节剂 VISTA 在人乳腺癌中的表达模式及临床意义。
Front Immunol. 2020 Oct 29;11:563044. doi: 10.3389/fimmu.2020.563044. eCollection 2020.
9
Correction to: Silver-coated (PorAg®) endoprosthesis can be protective against reinfection in the treatment of tumor prostheses infection.对以下内容的修正：镀银（PorAg®）内置假体在治疗肿瘤假体感染时可预防再次感染。
Eur J Orthop Surg Traumatol. 2020 Dec;30(8):1355. doi: 10.1007/s00590-020-02725-z.
10
Dual silencing of tumor-intrinsic VISTA and CTLA-4 stimulates T-cell mediated immune responses and inhibits MCF7 breast cancer development.双重沉默肿瘤内在的 VISTA 和 CTLA-4 可刺激 T 细胞介导的免疫反应并抑制 MCF7 乳腺癌的发展。
Gene. 2024 Feb 20;896:148043. doi: 10.1016/j.gene.2023.148043. Epub 2023 Nov 30.
引用本文的文献
1
Update on current and new potential immunotherapies in breast cancer, from bench to bedside.乳腺癌当前及新的潜在免疫疗法进展：从实验室到临床应用
Front Immunol. 2024 Feb 15;15:1287824. doi: 10.3389/fimmu.2024.1287824. eCollection 2024.
2
Characterization of Immune Cell Subsets of Tumor Infiltrating Lymphocytes in Brain Metastases.脑转移瘤中肿瘤浸润淋巴细胞免疫细胞亚群的特征分析
Biology (Basel). 2021 May 11;10(5):425. doi: 10.3390/biology10050425.
Zotero 插件